Allele-specific recognition of the 3′ splice site of INS intron 1 by Kralovicova, Jana & Vorechovsky, Igor
Hum Genet (2010) 128:383–400
DOI 10.1007/s00439-010-0860-1
123
ORIGINAL INVESTIGATION
Allele-speciWc recognition of the 3 splice site of INS intron 1
Jana Kralovicova · Igor Vorechovsky 
Received: 10 May 2010 / Accepted: 30 June 2010 / Published online: 14 July 2010
© The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract Genetic predisposition to type 1 diabetes (T1D)
has been associated with a chromosome 11 locus centered
on the proinsulin gene (INS) and with diVerential steady-
state levels of INS RNA from T1D-predisposing and
-protective haplotypes. Here, we show that the haplotype-
speciWc expression is determined by INS variants that con-
trol the splicing eYciency of intron 1. The adenine allele at
IVS1-6 (rs689), which rapidly expanded in modern
humans, renders the 3 splice site of this intron more depen-
dent on the auxiliary factor of U2 small nuclear ribonucleo-
protein (U2AF). This interaction required both zinc Wngers
of the 35-kD U2AF subunit (U2AF35) and was associated
with repression of a competing 3 splice site in INS exon 2.
Systematic mutagenesis of reporter constructs showed that
intron 1 removal was facilitated by conserved guanosine-
rich enhancers and identiWed additional splicing regulatory
motifs in exon 2. Sequencing of intron 1 in primates
revealed that relaxation of its 3 splice site in Hominidae
coevolved with the introduction of a short upstream open
reading frame, providing a more eYcient coupled splicing
and translation control. Depletion of SR proteins 9G8 and
transformer-2 by RNA interference was associated with
exon 2 skipping whereas depletion of SRp20 with increased
representation of transcripts containing a cryptic 3 splice
site in the last exon. Together, these Wndings reveal critical
interactions underlying the allele-dependent INS expression
and  INS-mediated risk of T1D and suggest that the
increased requirement for U2AF35 in higher primates may
hinder thymic presentation of autoantigens encoded by
transcripts with weak 3 splice sites.
Abbreviations
INS Gene for human proinsulin
T1D Type 1 diabetes
IDDM2 T1D susceptibility locus
VNTR Variable number of tandem repeats
U2AF Auxiliary factor of the U2 small nuclear
ribonucleoprotein
U2AF65 65-kD subunit of U2AF
U2AF35 35-kD subunit of U2AF
hnRNPs Heterogenous nuclear ribonucleoproteins
SR proteins Serine/arginine-rich proteins
PPT Polypyrimidine tract
PTB Polypyrimidine tract-binding protein
ES Exon skipping
IR Intron retention
ZF Zinc Wnger
3 and 5ss 3 and 5 splice sites
Introduction
The majority of vertebrate genes contain introns that must
be removed from precursor messenger RNA (pre-mRNA)
by splicing to ensure correct gene expression (Burge et al.
1999). This process requires pre-mRNA signals at the 5
and 3 splice sites (5ss and 3ss), branch points, polypy-
rimidine tracts (PPTs) and splicing silencers and enhancers
that inhibit or promote exon inclusion in mRNA by altering
RNA structure and/or binding of splicing factors, such as
serine/arginine-rich (SR) proteins or heterogenous nuclear
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ribonucleoproteins (hnRNPs) (Burge et al. 1999). Because
silencers and enhancers are highly prevalent in both exons
and introns, a signiWcant fraction of naturally occurring
gene variability that confers a risk of genetic disease may
operate at the level of pre-mRNA splicing (Graveley 2008;
Kralovicova et al. 2004). The splicing process is, however,
tightly coupled to other gene expression pathways, includ-
ing transcription, polyadenylation, mRNA export and trans-
lation (Maniatis and Reed 2002; Moore and Proudfoot
2009). For example, promoter strength, RNA polymerase II
elongation rate and transcriptional activators have been
shown to alter splicing; conversely, eYcient intron removal
by the spliceosomal machinery promotes transcription
(Brinster et al. 1988; de la Mata et al. 2003) and translation
(Nott et al. 2004). However, the extent to which splicing
variants contribute to disease susceptibility at each level is
poorly understood.
Type 1 diabetes (T1D) results from insulin deWciency
caused by the autoimmune destruction of pancreatic  cells.
T1D aetiology has a strong genetic component, which is
conferred by the major histocompatibility complex and a
number of modifying chromosome loci (Davies et al.
1994). The strongest modiWer was identiWed in the proinsu-
lin gene (INS) region on chromosome 11 (termed IDDM2)
(Davies et al. 1994) and Wne-mapping of IDDM2 suggested
that  INS is the most likely IDDM2 target (Barratt et al.
2004). The genetic risk to T1D at IDDM2 has been attributed
to diVerential steady-state RNA levels transcribed from
predisposing and protective haplotypes, potentially involv-
ing a minisatellite sequence upstream of INS, termed
VNTR (Barratt et al. 2004; VaWadis et al. 1997) and refer-
ences therein). However, the underlying mechanism that
would link the VNTR to altered INS expression and T1D
susceptibility has been elusive. In addition, reanalysis
of IDDM2 genotypes in T1D families did not support the
original  Wnding of a diVerence in association between
VNTR lineages that had previously enabled the exclusion
of intragenic polymorphisms (Barratt et al. 2004).
Here, we demonstrate that diVerential mRNA and proin-
sulin expression from T1D-susceptibility and -protective
haplotypes is due to INS variants that control the eYciency
of intron 1 removal from the pre-mRNA. We also show that
the adenine allele at rs689 (IVS1-6A/T), a critical polymor-
phism in this process, impairs recognition of the 3ss of
intron 1 by the auxiliary factor of U2 small nuclear RNP
(U2AF). This interaction required both zinc Wnger domains
of the 35-kD U2AF subunit, which inhibited a competing
3ss in INS exon 2. The increased requirement for U2AF35
coevolved with the relaxation of 3ss in higher primates and
is here proposed to restrict thymus presentation of autoanti-
gens encoded by alleles containing weak 3ss.
Materials and methods
Reporter constructs
Reporter constructs and their splicing products are summa-
rized in Fig. 1a and their haplotypes in Fig. 1b. Cloning of
reporters A–C and D–E was described previously (Kralovi-
cova et al. 2006a). D–F constructs were obtained with
primer F (5-cat gcc tgc tat tgt ctt ctc caa gag tcc aga gct
act), which contains the BbsI site (underlined). For cloning,
we employed previously haplotyped DNA samples as a
template for PCR (Stead et al. 2003). The VNTR-contain-
ing reporter, which has a minisatellite sequence upstream of
the IC haplotype constructs, was obtained by cloning PCR
products ampliWed with primers J (5-atc caa gct tgt cct aag
gca ggg tgg gaa cta; HindIII site is underlined) and C into
pCR3.1 and propagated in bacterial cells with genotypes
designed to stabilize direct repeats (MAX EYciency Stbl2,
Invitrogen). Stable propagation of highly repetitive ele-
ments of class III haplotypes was unsuccessful even in this
system. Two-exon minigenes were cloned into HindIII/
XbaI sites using primers K (5-ata aag ctt atc act gtc ctt ctg
cca) and R (5-ata tct aga atg ggc agt tgg ctc acc c)
(Fig. 1a).
Intron 1 and exon 2 deletion constructs were prepared
using overlap-extension PCR as described (Kralovicova
and Vorechovsky 2007). Serial deletions of intron 1
were made with the D–E reporter that lacked intron 2.
For adenovirus preparation, the D–F constructs carrying
haplotypes IC and IIIA were cut with BbsI, Wlled with
the Klenow enzyme and subcloned into HindIII and
blunted BglII sites of the shuttle plasmid pVQ-CMV-K-
NpA (Anderson et al. 2000). Viruses were produced by
recombination as described (Anderson et al. 2000) and
supplied by ViraQuest Inc. (North Liberty, IA, USA).
Adenovirus was puriWed over two rounds of CsCl gradi-
ents and was dialyzed against a storage buVer (Anderson
et al. 2000).
The U2AF35 reporters were cloned into BamHI/EcoRI
sites of pcDNA3.1/His (Invitrogen) using primers 5-att
gga tcc tgg gaa atg gcg gag tat ctg and 5-ata gaa ttc ata agg
taa aaa tgg cat ggc. Plasmids containing the 65-kD subunit
of U2AF were subcloned into BamHI/XhoI sites of the
same vector. ZRSR2 was prepared as a BamHI and XhoI
amplicon with primers 5-ata gga tcc gcg ccc gag aag atg
acg tt and 5-atc ctc gag tta ttt gga ttt ggg act ctg. Murine
U2AF26 was cloned into BamHI/EcoRI sites of pcDNA3.1/
His using primers 5-ata gga tcc cgg gta aaa atg gct gaa ta
and 5-atc gaa ttc ccg tct cag aag cga cca tgc. Mammalian
expression constructs encoding splicing factors were as
described (Kralovicova et al. 2004).Hum Genet (2010) 128:383–400 385
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Cell culture and RNA/cDNA preparations
Cells were cultured as previously described (Kralovicova
et al.  2004,  2006a). Transfections of reporter constructs
were carried out in 6- or 12-well plates using siPORT XP-1
(Ambion, USA). Total RNA was extracted using TRI
reagent (Ambion) 48 h post-transfection, treated with
DNase I (DNA-free™; Ambion, USA) and transcribed
using the Moloney murine leukaemia virus reverse trans-
criptase (Promega, USA) and oligo-d(T)15 according to the
manufacturers’ recommendations.
Detection of spliced products and real-time PCR
RNA products of transfected plasmids were visualized
using RT-PCR with vector primers described previously
Fig. 1 Haplotype-dependent 
proinsulin expression is 
determined by INS variants in 
intron 1. a INS splicing and 
reporter constructs. Exons 1, 2 
and 3 are shown as black, grey 
and white boxes, respectively. 
Thick lines denote introns, 
dotted lines represent mRNA 
isoforms (numbered in circles). 
Primers and the most important 
gene variants are shown by grey 
and black arrows, respectively. 
The VNTR is denoted by closely 
spaced vertical lines. Cryptic 
splice sites are shown as black 
rectangles. b The INS haplotype 
structure and corresponding 
wild-type (boxed) and mutated 
reporter constructs. Variant 
nucleotides are highlighted. 
Designation of INS variants and 
haplotypes is as described (Stead 
et al. 2003); IVS intervening 
sequence or intron. c Haplotype-
dependent proinsulin expression 
(upper panel) and corresponding 
relative mRNA levels (lower 
panel). The mean ratios of INS 
mRNA to RNA transcribed from 
the vector neomycin gene (neo) 
are shown as dark grey bars; the 
relative expression of endoge-
nous -actin is shown as light 
grey bars. Error bars represent 
s.d. d Splicing pattern of the INS 
reporter constructs. M 100-nt 
size marker. RNA isoforms are 
shown schematically to the right 
and are also numbered as in a. 
Percentage of splicing of each 
isoform is shown at the bottom, 
except for isoform 1 (expressed 
at <1%). AmpliWcation was with 
primers PL3 (Kralovicova et al. 
2006a) and E386 Hum Genet (2010) 128:383–400
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(Kralovicova et al. 2004, 2006a). A combination of cDNA
and vector primers was used as indicated to validate the
ratios of RNA products. RT-PCR ampliWcations were for
28 cycles to maintain approximately linear relationship
between the RNA input and signal. PCR products were sep-
arated on 6% polyacrylamide gels and stained with ethi-
dium bromide. Signal intensity from alternatively spliced
products was quantiWed as described (Kralovicova et al.
2004). To conWrm the identity of each product, DNA frag-
ments were excised from the gels and sequenced.
For real-time PCR, we used the FAM-labelled TaqMan
probe (5-ccc tcc agg aca ggc tgc atc ag), a forward primer
(5-cca agc tgg cta gcg ttt aaa) and reverse primers directed
to exon 1 [5-(a/g/c/t)(a/g/c)c tgc ttg atg gcc tctt] or exons 1
and 2 (5-aga agg aca gtg atc tgc ttg). The former reverse
primer ampliWes all transcripts, whereas the latter detects
correctly spliced RNAs lacking intron 1. Transcripts from
the neomycin gene in pCR3.1 were measured by real-time
PCR with primers neo-R (5-gcc gga tca agc gta tgc) and
neo-F (5-ctc ctg ccg aga aag tat cca) and the TaqMan
probe 5-cgc cgc att gca tca gcc at. The endogenous
expression of -actin was quantiWed as described (Kralovi-
cova and Vorechovsky 2005). For all real-time PCR experi-
ments, we employed the 7700 sequencer and the SDS
analysis software (ABI). Standard curves were constructed
using serial dilutions of the corresponding plasmid DNA
as described previously (Kralovicova and Vorechovsky
2005).
Alternatively spliced U2AF35 isoforms were visualized
by a HinfI digest using PCR primers reported previously
(Pacheco et al. 2004). Dual-speciWcity splice sites in
DIABLO and UBE2C were ampliWed as described (Zhang
et al. 2007).
Expression and puriWcation of recombinant proteins
The pET28a-PTB-His construct was generously provided
by D. Black (UCLA). The pET28a-PUF60-His was pre-
pared by subcloning a BamHI-EcoRI fragment of the
pcDNA3.1-PUF60 vector (cloning primers 5-caa gat ggc
gac ggc gac c and 5-gag agg gac cac tgt cac g). Following
transformation, BL21 Star cells (Invitrogen) were grown to
optical density of 0.8 at 37°C. Protein expression was
induced with 0.25 mM IPTG for 3 h. Pellets were resus-
pended in a lysis buVer (50 mM Tris, pH 8.0, 300 mM
NaCl, 1 mM DTT) and sonicated. Proteins were puriWed
from supernatant using the Ni–NTA agarose (Qiagen).
Bound proteins were eluted using 250 mM imidazole,
50 mM Tris and 300 mM NaCl and dialysed against buVer
D (25 mM Tris, pH 7.5, 1 mM DTT, 300 mM NaCl, 15%
glycerol).
Recombinant U2AF65 were produced as GST fusion
proteins with pGEX6P-U2AF65 generously provided by
Berglund (Berglund et al. 1998). U2AF65 was puriWed
from the BL21 cell lysate using Glutathione Sepharose 4B,
cleaved from the GST tag with the PreScission protease
(GE Healthcare) and dialysed. Protein concentrations were
measured using the Bradford assay (Biorad) and by com-
paring protein preparations to serial dilutions of bovine
serum albumin on SDS-PAGE gels stained with Coomassie
Brilliant Blue G (Sigma).
Gel shift assays
Oligoribonucleotides (MWG Biotech) were 5 end-labeled
with [-32P]ATP (3000 Ci/mmol; PerkinElmer) and T4
polynucleotide kinase (Promega), gel puriWed and incu-
bated with the indicated protein concentrations at room
temperature for 15 min. The reaction mix (0.5 nM of
labeled oligoribonucleotide, 50 mM Tris, pH 7.5, 70 mM
NaCl, 1 mM DTT, 3.5% glycerol, 5 mM MgCl2, 0.25 mg/
mL heparin, 0.3 mg/mL BSA, and 2U RNasin) was loaded
onto native polyacrylamide gels (5%, 37.5:1 mono:bis
acrylamide, 0.5xTBE) and run at 100 V at 4°C for 2 h. Gels
were dried and exposed to phosphor screens. The signal
was measured using the ImageQuant TL software (Amer-
sham). For competition experiments, the indicated concen-
trations of unlabeled oligoribonucleotides were added to
the protein-RNA complex after 15 min incubation for addi-
tional 10 min before gel loading.
Western blot analysis
Cells were washed twice with PBS and lysed in RIPA
buVer (150 mM NaCl, 1% NP-40, 0.5% deoxycholate,
0.1% SDS, 50 mM Tris, pH 8.0). Equivalent amount of
protein lysates were loaded on 10% SDS-PAGE gels and
transferred to PVDF (Amersham) membranes. The mem-
branes were incubated with mouse PTB (kindly provided
by Smith), mouse Puf60 (generously provided by Krainer),
mouse U2AF65 (Sigma), rabbit U2AF35 (Protein Tech
Group), mouse tubulin (ABcam) and rabbit actin (ABcam)
antibodies and appropriate horse radish peroxidase-conju-
gated secondary antibodies (ABcam). Protein bands were
detected using the Immun-Star WesternC Kit (Biorad)
according to the manufacturer’s instructions.
RNA interference
Mammalian cells were plated at 8 £ 104 cells per well in
12-well plates to achieve »40% conXuence. The next day,
HiPerFect (Qiagen) was combined with Opti-MEM
medium (Invitrogen) and siRNAs (MWG Biotech). Before
adding to cells, the mixture was left at room temperature
for 20 min. Cells were transfected with reporter constructs
48 h later and harvested after additional 24 h.Hum Genet (2010) 128:383–400 387
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For rescue experiments, the cells were split into 6-well
plates following the initial hit with either U2AF35-UTR or
U2AF35ab siRNAs. Next day, the cells received the second
hit. After 8 h, they were co-transfected with the reporter
and rescue plasmids using the FuGENE HD transfection
reagent (Roche) and 48 h later, they were harvested for pro-
tein/RNA isolation. For depletion experiments with
U2AF35ab, we introduced silent mutations in the targeted
region of rescue plasmids using a primer 5-gaa aag gct gta
atc gat tta aat aac cgt tgg tt. Final PCR products were
inserted into NheI/NotI sites of the pCI vector (Promega).
Proinsulin secretion
Total proinsulin levels were measured in coded samples of
culture supernatants by dissociation-enhanced lanthanide
Xuoroimmunoassay using monoclonal antibodies 3B1 and
CPT3F11 as described (Kralovicova et al. 2006a).
Statistical analysis
Multiple comparisons of exogenous INS/neo mRNA
expression across experiments were carried out with the
SigmaStat (v. 3.5; Systat Software Inc., USA) and XLStat
2007 using the Fisher LSD and Holm-Sidak methods.
Spearman correlation coeYcients shown throughout the
text were computed with the SigmaStat.
Results
Haplotype-dependent proinsulin expression is determined 
by diVerential splicing eYciency of INS intron 1
To identify gene variants that contribute to the allele-spe-
ciWc INS expression, we prepared reporter constructs carry-
ing T1D-predisposing (class IC) and -protective (class IIIA
and IIIB) haplotypes (Fig. 1a, b). These haplotypes are
common in population and diVer at only 5 of 14 known INS
polymorphisms (Stead et al. 2003). We transiently
expressed the wild-type reporters in 293T and HeLa cells,
examined their splicing pattern, measured their steady-state
mRNA levels and determined the proinsulin concentration
in culture supernatants. Cells expressing the class IC haplo-
type secreted less proinsulin than those with class III haplo-
types (Fig. 1c, upper panel), which was mirrored by their
steady-state mRNA levels, as measured by real-time PCR
with TaqMan probes in the Wrst INS exon and in the neomy-
cin gene of the vector (lower panel). Visualization of alter-
natively spliced RNA products using RT-PCR conWrmed
that the reporter constructs with adenine (A) at position
IVS1-6 (also known as rs689, INS-27 or HphI+/¡) showed
an increased intron retention (IR) and exon skipping (ES)
as compared to those with the T allele (cf. isoforms 6 and 2
in lanes 2, 5 and 8; Fig. 1d).
Systematic mutagenesis of each variant revealed that the
A > T mutation at IVS1-6 introduced in the IC construct
increased mRNAs/proinsulin to levels observed for the
class III haplotypes (Fig. 1c). Conversely, the T > A muta-
tion in both class III reporters reduced proinsulin to levels
typical of the IC construct. In addition to IVS1-6, the 4-bp
insertion at IVS1+5ins4 (also known as INS-69ins4), which
activates a cryptic 5ss of intron 1 (Kralovicova et al.
2006a), increased IR and lowered proinsulin secretion, par-
ticularly on the class IC haplotype background (cf. lanes 4,
7 and 10; Fig. 1d). The remaining 12 polymorphisms
altered the relative expression of RNA products only to a
minor extent (INS-26), or not at all, despite creating/elimi-
nating predicted silencers/enhancers (Supplemental Fig. 1a,
b). The splicing pattern of constructs carrying African hap-
lotypes Ja, Ma and Ta (IVS1+5ins4) and Na, Va and Ya
(IVS1+5del4), which all have the T allele at IVS1-6 and a
wide range of class I, II and III VNTRs (Stead et al. 2003),
was also similar. The addition of »0.5 kb sequence
upstream of INS containing the class I VNTR did not inXu-
ence the INS splicing either (Supplemental Fig. 1c, d).
Finally, the allele-speciWc splicing pattern was conWrmed
upon transfection/transduction of plasmid/adenovirus
reporter constructs into mouse thymic epithelial cell lines, a
macrophage cell line and control cells (Supplemental
Fig. 2a).
Together, these results demonstrate that IVS1-6T/A and
IVS1+5ins/del4 are key variants underlying the haplotype-
dependent proinsulin expression through altered eYciency
of intron 1 splicing. These Wndings support a model, in
which T1D predisposition at IDDM2 results from a failure
to adequately present proinsulin peptides of the low-
expressing and T1D-predisposing IVS1-6A allele in the
developing thymus (Supplemental Fig. 2b).
IdentiWcation of splicing regulatory elements 
in INS intron 1
Although the haplotype-speciWc INS expression is largely
determined by intron 1 variants, this intron may contain
additional signals that may improve its splicing eYciency
and can be exploited in the future to correct the defect. To
identify these motifs, we systematically examined splicing
and proinsulin secretion of reporter constructs with a series
of overlapping deletions (Fig. 2a). IR levels were altered in
9/14 deletion mutants and correlated positively with the G
content of deleted segments (r =0 . 6 2 ,   P < 0.01, F test) and
negatively with their C (r = ¡0.47,  P < 0.05) and A
(¡0.43,  P = 0.05) contents (Fig. 2b). Each deletion that
increased IR also removed one or more Gn (where n >2 )
repeats, except for del14, which encompassed a predicted388 Hum Genet (2010) 128:383–400
123
branchpoint and showed an increased ES. In contrast, IR
was diminished for deletions that recreated these motifs
(del5, del9), except for del6, which lacked a G repeat alto-
gether. The concentration of secreted proinsulin correlated
negatively with IR (r = ¡0.66,  P < 0.01) and positively
with mRNA levels (r =0 . 8 9 ,   P < 0.0001). In cells depleted
of hnRNP F and H, which were shown to recognize G-rich
motifs (Caputi and Zahler 2001), IR was increased whereas
transcripts spliced to cryptic 3ss in exon 3 (cr3ss+126)
were diminished. In contrast, transient overexpression of
hnRNPs H/F in 293T cells revealed the opposite pattern
(Supplemental Fig. 3).
To determine the importance of each G run, we intro-
duced G > C substitutions in their central residues.
Remarkably, each substitution signiWcantly increased IR,
but only to a minor extent. In addition, two of these substi-
tutions activated a cryptic 5ss at position +30 of intron 1
(cr5ss+30), but only one of them (G4 in Fig. 2c) mediated
a long-range interaction. Deletions containing CCC triplets
(del5, del11 and del12, Fig. 2b) that may act as splicing
regulatory elements (Kennedy and Berget 1997; Murray
et al. 2008) did not show consistent IR changes.
Together, intron 1 splicing was facilitated by G-rich
enhancers that appeared to act additively to increase INS
expression, possibly through interactions with hnRNPs F/H
and/or structural RNA motif(s) required for the cr5ss+30
inhibition. These results also revealed a G > C>C > T hier-
archy in regulatory signals that facilitate intron 1 removal
and conWrmed the importance of eYcient splicing for
mRNA/protein expression.
Primate evolution of coupled splicing and translation 
regulatory elements in the 5 untranslated region
If G runs are functionally important for eYcient intron 1
splicing, they should be conserved in evolution. To test
this, we sequenced intron 1 in a number of primate species
(Supplemental Fig. 4). Multiple sequence alignments
revealed that all G triplets were absolutely conserved in
Great Apes and Old World Monkeys, while most of them
Fig. 2 IdentiWcation of splicing enhancers and silencers in INS intron
1.  a Intron 1 deletion constructs. Deletions 1–14 (horizontal lines)
were made in reporter D–F on the IC haplotype background. G-runs
(boxed) were numbered G1–G7; G > C substitutions in their central
residues are denoted by arrows. 5ss GT and 3ss AG dinucleotides are
highlighted in grey; stars denote predicted branchpoints. Variant alle-
les are indicated by arrowheads.  b Intron retention, steady-state
mRNA levels and proinsulin secretion of wild-type and deletion con-
structs. Error bars indicate s.d. determined from transfection experi-
ments in duplicate. Secreted proinsulin was measured in culture
supernatants 48 h post-transfection with 750 ng of the indicated report-
er plasmid DNA. c Cytosine substitutions of central guanosines in Gn
runs increase intron 1 retention and lower proinsulin secretion. Stars
indicate activation of the cryptic 5ss at position +30 of intron 1Hum Genet (2010) 128:383–400 389
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were present in New World Monkeys and Strepsirrhini
(Supplemental Table 1).
Of two large intron 1 deletions that took place during
primate evolution, only the Hominini-speciWc event inXu-
enced splicing by enhancing IR, most likely by eliminating
a G5-containing enhancer, whereas the largest but splicing-
neutral deletion was observed in colobines (Supplemental
Figs. 4, 5). A G > A transition 24 nucleotides upstream of
the 3ss, which was found only in orangutans, was pre-
dicted to alter branchpoint position in this species (Supple-
mental Fig. 6). However, the most important ancestral
event at intron 1 splice sites was a Hominidae-speciWc sub-
stitution at Wrst position of exon 2 (E2+1G > A), which
reduced the predicted strength of this 3ss (Supplemental
Table 2).
In addition to splicing signals, Homininae acquired a
short upstream open reading frame, which encodes a 3-aa
peptide (uORF2 in Fig. 3a). Because intron 1-containing
transcripts are eYciently exported from the nucleus (Wang
et al. 1997) and are overrepresented in expressed sequenced
tags with the class IC haplotype as compared to the class III
haplotypes (Kralovicova et al. 2006a), this uORF may cur-
tail translation and further contribute to the lower proinsu-
lin output of unspliced transcripts. To test this, we
examined RNA and proinsulin levels for reporters with
serial, 12- to 14-nt deletions of intron 1. As expected, con-
structs lacking the short uORF exhibited high levels of pro-
insulin secretion. In contrast, proinsulin concentration was
diminished for uORF-containing reporters, except for dele-
tion constructs capable of intron 1 splicing, in which the
increase in proinsulin levels was roughly proportional to
the spliced fraction (Fig. 3b).
In contrast to Homininae, all Old and New World
Monkeys had a distinct uORF further upstream that was
in-frame with the canonical start codon (uORF1 in Fig. 3a).
The GTG > ATG mutation creating uORF1 in the D-F con-
struct increased IR/ES and lowered proinsulin secretion
(Supplemental Fig. 7). In contrast, the ATG > GTG muta-
tion in uORF2 had a negligible eVect on intron 1 splicing,
but raised proinsulin secretion. Interestingly, orangutans
lacked intron 1 uORFs altogether (Fig. 3a, Supplemental
Fig. 4). As predicted by calculating the intrinsic strength of
3ss, reporter constructs carrying G at the Wrst position of
exon 2, which is speciWc for lower primates, consistently
generated less IR/ES and more proinsulin than the A-con-
taining constructs.
Taken together, splicing of intron 1 was weakened in
higher primates by the 3ss mutation E2+1G > A in Homini-
dae and the 16-nt deletion in Homininae, which was com-
pensated by coupled splicing (G-rich intronic enhancers)
and translational (loss of uORF1, gain of uORF2) regula-
tory motifs. Evolution of splicing regulatory motifs in
intron 1 culminated in further relaxation of the 3ss upon
Wxation of the IVS1-6A allele in modern humans, providing
a means of rapidly Wne-tuning INS expression, but reducing
the intron-mediated translational yield. We propose that
this reduction could result in insuYcient pool of antigenic
peptides for presentation in the foetal thymus and T1D sus-
ceptibility (Supplemental Figs. 2, 9).
Interactions of poly(Y)-binding proteins with IVS1-6
Experiments described so far indicated that the allele-spe-
ciWc  INS expression is determined by the eYciency of
intron 1 removal through two natural variants IVS1+5ins/
del4 and IVS1-6A/T located at its 5ss and 3ss, respec-
tively, and is inXuenced by a number of regulatory motifs,
some of which apparently compensate for the 3ss relaxa-
tion in higher primates. Because genetic susceptibility to
T1D at IDDM2 in the white population cannot be attributed
to the African-speciWc insertion IVS1+5ins4, we set out to
characterize RNA interactions aVected by IVS1-6A/T.
Since the IVS1-6A allele weakens the PPT and may reduce
binding of U2 snRNP auxiliary factor (U2AF) and/or other
poly(Y)-binding proteins, including PTB (Sauliere et al.
2006; Singh et al. 1995) and PUF60 (Hastings et al. 2007;
Page-McCaw et al. 1999), we Wrst determined their binding
aYnity to the 3ss sequences in vitro. Synthetic, end-
labeled oligoribonucleotides representing IVS1-6A, IVS1-
6T and a strong PPT as a control were incubated with
recombinant U2AF65, PUF60 and PTB (Fig. 4a). Binding
of each protein to the A allele was weaker as compared to
the T allele and a T-rich control (Fig. 4b–d), which was
more pronounced for PTB and PUF60 than for U2AF65
and which was further supported by competition experi-
ments with unlabelled RNA probes (Fig. 4e).
Interestingly, RNA interference-mediated depletion of
each poly(Y)-binding protein (Fig. 4f) revealed that IR was
increased and utilization of cr3ss+126 was decreased in
U2AF65-depleted cells, but both PTB- and PUF60-
depleted cells exhibited the opposite pattern. The same out-
come of U2AF65/PTB/PUF60 depletion was observed also
for the IVS1-6T allele and D–F constructs (Fig. 4g and data
not shown) and for other 3ss, such as LIPC intron 1, point-
ing to a more general role of these proteins in 3ss control
(J.K., I.V, manuscript in preparation). Thus, although bind-
ing to the IVS1-6A allele was reduced in vitro, U2AF65
acted antagonistically to PTB and PUF60 in vivo, implicat-
ing additional interactions.
T1D-protective allele at IVS1-6 relieves the requirement 
of intron 1 splicing for U2AF35
Recruitment of the U2 snRNP to the branch site is facili-
tated by the U2AF heterodimer, which consists of the PPT-
interacting U2AF65 (Zamore and Green 1989) and the390 Hum Genet (2010) 128:383–400
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3AG-binding U2AF35 (Merendino et al. 1999; Wu et al.
1999; Zorio and Blumenthal 1999). Because interaction
between U2AF35 and 3AG can stabilize U2AF65 binding
to weak PPT (Merendino et al. 1999; Wu et al. 1999), we
tested if the A allele at IVS1-6 renders the 3ss of intron 1
more dependent on U2AF35. Interestingly, RNA interfer-
ence-mediated U2AF35 depletion in Hela cells (Fig. 5a;
Supplemental Fig. 9) increased IR and ES, but also acti-
vated a cryptic 3ss 81 nucleotides downstream of the
authentic 3ss (cr3ss+81) and inhibited cr3ss+126 of
intron 2 (Fig. 5b). Importantly, the 3ss requirement for
U2AF35 was dramatically relieved for the IVS1-6T allele
and also for the E2+1G mutation, which is characteristic of
lower primates (Fig. 3a). The U2AF35-speciWc splicing
pattern was observed with additional three small interfering
RNAs (siRNAs) targeting this protein, but never for scram-
bled controls or siRNAs against >30 other splicing factors
(see below). The same change in utilization of both cryptic
3ss was found in U2AF35-deWcient cells transfected with
reporters containing only exons 1–2 and exons 2–3
Fig. 3 Evolution of coupled splicing and translational regulation of
the proinsulin gene. a Primate phylogeny of upstream open reading
frames and 3ss of intron 1. uORFs are shown as black rectangles.
Their position in the 5 untranslated region is shown at the top. OWM/
NWM, Old/New World Monkeys. b Upstream open reading frame in
INS intron 1 is a dominant regulatory motif inhibiting translation.
Proinsulin secretion in culture supernatants of 26 constructs with serial
12- to 14-nt deletions transiently transfected into 293T cells. Deletion
constructs (left panel) were derived from a reporter lacking intron 2
because this intron is spliced much more eYciently than intron 1 and
has a strong translation-enhancing eVect (data not shown). Thin hori-
zontal lines represent deleted segments of intron 1, thick lines indicate
the remaining sequence. Homininae-speciWc upstream open reading
frame is denoted by a grey vertical column; encoded amino acids are
shown at the bottom. Schematic representation of deletions is followed
by their splicing pattern (middle panel). The right panel shows proin-
sulin concentrations in cultures; error bars represent s.d. Stars denote
reporter constructs that were spliced; the percentage of splicing is
shown in parenthesesHum Genet (2010) 128:383–400 391
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(Fig. 5c), indicating that they are used independently of
each other. Depletion of U2AF65, which also reduced
U2AF35 levels (Pacheco et al. 2006a) (Supplemental
Fig. 9), did not activate cr3ss+81, whereas codepletion of
both U2AF subunits reduced its use as compared to the
U2AF35 depletion (Fig. 5d). Separate knockdown of
alternatively spliced isoforms U2AF35a and U2AF35b
(Pacheco et al. 2004) did not induce cr3ss+81, but their
combination was eVective (Fig. 5e, f). Overexpression of
wild-type U2AF plasmids in cells symmetrically depleted
of both subunits resulted in more dramatic alterations of
relative U2AF35/U2AF65 levels. A higher U2AF35/
U2AF65 ratio was associated with lower IR. In contrast,
cr3ss+126 was repressed when the ratio was altered in
either direction, whereas cr3ss+81 was preferred only at
low U2AF35/U2AF65 ratios (Fig. 5g).
Although binding of U2AF35 to 3AG is well-estab-
lished (Merendino et al. 1999; Wu et al. 1999; Zorio and
Blumenthal 1999), it has been unclear which residues con-
tact RNA and how these interactions control 3ss selection.
U2AF35 contains two C3H-type zinc Wngers (ZF1, ZF2),
highly prevalent eukaryotic domains increasingly impli-
cated in RNA binding (Lai et al. 2002; Liang et al. 2008).
To test the importance of ZF1/ZF2, we made a series of
substitutions of U2AF35 amino acids that corresponded to
RNA-interacting residues in tristetraprolin/TIS11d, the best
studied C3H ZF proteins (Hudson et al. 2004; Lai et al.
2002) (Fig. 5h, upper panel). Unlike the wild-type plasmids
expressing U2AF35a and U2AF35b isoforms, substitutions
C33R in ZF1 and C169R in ZF2 failed to rescue the INS
splicing pattern in U2AF35 deWcient cells (Fig. 5h, lower
panel). Interestingly, a partial rescue phenotype was
observed for a conservative substitution F171Y in ZF2, but
not for F171L, in agreement with similar RNA binding
aYnities of tristetraprolin mutants containing identical sub-
stitutions at F164 (Lai et al. 2002). Corresponding positions
in TIS11d and MBNL1 were essential for high-aYnity
RNA binding by forming stacking interactions with RNA
bases (Hudson et al. 2004; Teplova and Patel 2008).
U2AF35 carrying a substitution of T45, a residue
Fig. 4 Interaction of poly(Y)-binding proteins with allele-speciWc INS
transcripts. a Oligoribonucleotides representing IVS1-6A and IVS1-
6T alleles and a control (AV3) used in gel shift experiments shown in
b–d. b Concentration of recombinant U2AF65 was 0.14, 0.28, 0.56,
1.12, 2.24 and 4.48 M. C, protein-RNA complex; F, free probe; %C,
% bound. c Concentration of recombinant PUF60 was 0.34, 0.68, 1.36,
2.72, 5.44 and 10.88 M. d Concentration of recombinant PTB was
0.32, 0.64, 1.28, 2.56 and 5.12 M. e Example of a competition exper-
iment with PUF60, 32P-labeled T probe and increasing concentrations
of unlabeled competitors. f Western blot analysis of 293T cells trans-
fected with siRNAs shown at the top (in duplicate); antibodies are
shown at the bottom. The lower band corresponds to -tubulin in each
panel. sc, scrambled control siRNAs with the indicated GC content.
g Opposite eVects of U2AF65 and PUF60/PTB on intron 1 retention
and activation of cryptic 3ss +126. siRNAs (100 nM each) are at the
top, reporters are at the bottom, spliced products to the right392 Hum Genet (2010) 128:383–400
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previously proposed to contact RNA (Kielkopf et al. 2001),
had no obvious eVect on U2AF35 activity as well as a
C-terminal deletion removing amino acids 195–240 that
constitute the RS domain. Finally, INS splicing was also
partially rescued by U2AF35-related proteins, namely by
murine U2AF26 and human ZRSR2, but not by ZRSR2
lacking ZF2 or by empty plasmids (Fig. 5h and data not
shown).
U2AF35 has a preference for 3AGs that are followed
by G at the Wrst exon position (Wu et al. 1999). To
test whether this preference is maintained for the
U2AF35-sensitive cr3ss+81, we mutated the Wrst exon
Fig. 5 IVS1-6T relieves the requirement of intron 1 splicing for
U2AF35. a Western blot analysis of HeLa cells transfected with the
U2AF35ab siRNA (Wnal concentration of 3, 9, 27 and 81 nM) sc
scrambled control (68% GC). Antibodies are shown to the right. b RT-
PCR with total RNA extracted from HeLa cells that were transfected
with INS reporters shown at the bottom. The wild-type reporter D–F
contained haplotype IC. RNA products are to the right. Sequence chro-
matogram shows activation of cr3ss+81. c Splicing pattern of two-
exon minigenes in U2AF35-depleted cells. Final concentration of
U2AF35ab was 30 nM. Reporters are shown at the bottom; location of
cloning primers is shown in Fig. 1a. d Inhibition of 3ss+81 upon
cotransfection of U2AF35ab (30 nM) and U2AF65 K (45 nM)
siRNAs.  e INS splicing pattern upon separate knockdown of
U2AF35a and U2AF35b isoforms. The Wnal concentration of siRNAs
in each lane was 150 nM (100 nM of U2AF35a and 50 nM of
U2AF35b in lane 3). f The relative expression of U2AF35a and b
isoforms in HeLa cells transfected with siRNAs shown at the top. RT-
PCR products were digested with HinfI, which cuts only
U2AF35b (Pacheco et al. 2004). The last two lanes are HinfI-digested
PCR products ampliWed using template plasmids carrying U2AF35a-
and -b isoforms as controls. g upper panel. INS splicing pattern in cells
with varying U2AF35/U2AF65 ratios. The amount of wild-type plas-
mid DNAs (shown at the top) was 0.3, 1.0 and 3.0 g. siRNAs (shown
at the bottom) were added at Wnal concentrations of 90 nM
(U2AF65 K) and 10 nM (U2AF35ab). Lower panel shows Western
blot analysis with U2AF65 and U2AF35 antibodies. Ex, exogenously
expressed subunit. h upper panel. Multiple alignment of C3H ZF pro-
teins. Histidines and cysteines (numbered in U2AF35) coordinated to
zinc are highlighted in black, residues involved in base stacking inter-
actions in TIS11d in light grey and other TIS11d residues interacting
with RNA in dark grey. Lower panel, rescue of INS splicing with wild-
type and mutated U2AF35 isoforms. The extent of rescue is shown on
a semiquantitave scale, reXecting decrease of isoform 6 and cr3ss+81
upon cotransfection of U2AF35-depleted cells with the IC D–F report-
ers. Rescue plasmids are shown at the topHum Genet (2010) 128:383–400 393
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positions systematically and examined splicing of the
mutated constructs in U2AF35-depleted cells. We found
that the G>A>C>T hierarchy in splicing eYciency was
identical for both competing 3ss (Fig. 6a, b) and corre-
sponded to nucleotide frequencies at position +1 of
human exons and disease-causing pseudoexons (Fig. 6c–g).
These frequencies were very similar to those previously
obtained by in vitro U2AF35 selection (Wu et al. 1999).
We did not see activation of cr3ss+81 in cells treated
with siRNAs targeting other U2AF35- and -65 related
proteins, including ZRSR2/URP (Tronchere et al. 1997),
U2AF26 (Shepard et al. 2002) and CAPER and/or
CAPER (data not shown). U2AF35 was signiWcantly
depleted with U2AF35ab siRNA even at the very low
concentration (<1 nM), however, a faint U2AF35
signal was still detectable on Western blots at much
higher concentrations of this duplex (Supplemental
Fig. 10).
Taken together, the T1D-susceptibility allele IVS1-
6A and the ancestral E2+1A mutation increased the
requirement of intron 1 splicing for U2AF35. This inter-
action required both ZFs of U2AF35, which may employ
similar contacts with RNA as other C3H ZFs. Finally,
rather than by U2AF35- or U2AF65-related proteins,
selection of competing 3ss appeared to be controlled by
the balance between the small and large subunit of
U2AF, with cr3ss+81 preferred at low U2AF35 concen-
trations.
IdentiWcation of U2AF35-dependent 3 splice sites
Previous studies employing three-exon reporter constructs
demonstrated exon skipping as a result of U2AF35 deple-
tion in vivo (Pacheco et al. 2006a), suggesting that this pro-
tein may preferentially promote intron-proximal 3ss.
Rather than for splicing of all pre-mRNAs with a weak
PPT, U2AF35 appears to be required for a speciWc subset
of 3ss (Pacheco et al. 2006a). To extend and better deWne
this subset, we examined splicing of tandem 3ss on
endogenous transcripts (Akerman and Mandel-Gutfreund
2007) (Supplemental Table 3), minigenes with competing
3ss (Kralovicova et al. 2006b; Kralovicova and Vorechov-
sky 2007), and a CUED1 transcript as a positive control, in
which U2AF35 depletion promoted intron-distal 3ss
(Pacheco et al. 2006a). We also analyzed dual-speciWcity
splice sites that can be used as either 5ss or 3ss in endoge-
nous  DIABLO and UBE2C pre-mRNAs (Zhang et al.
2007). We observed a reproducible shift in 3ss utilization
for 4/14 (»29%) endogenous transcripts and for each mini-
gene and dual-speciWcity site (Supplemental Table 4).
Reporters containing short middle exons, such as DQB1
(Kralovicova et al. 2004) and TH (Kralovicova et al.
2006b), showed increased ES in U2AF35-depleted cells
(Supplemental Fig. 11 and 12; data not shown). Altogether,
intron-distal 3ss was promoted in 4 cases and intron-proxi-
mal 3ss in 7 cases. In U2AF65-depleted cells, we consis-
tently observed the same direction in the utilization of
Fig. 6 Splicing of INS reporters mutated at Wrst exon position of
authentic and cryptic 3ss of intron 1 upon U2AF35 depletion.
a Authentic 3ss.  b Cr3ss+81. The Wnal concentration of the
U2AF35ab duplex was 0, 3, 9 and 27 nM. RNA products are shown to
the right. The 3ss consensus of the wild-type reporters was CAG/A
(a) and CAG/C (b); their predicted intrinsic strength is shown in Sup-
plemental Table 2. c–g Consensus sequences for the Wrst 8 positions of
human exons. c 30 clones obtained after 6 rounds of selection with
U2AF35 (Wu et al. 1999). d 444 non-coding human exons (Zhang and
Chasin 2004). e 78 disease-causing human pseudoexons that were gen-
erated by intronic mutations, most of them in transposable elements
(Vorechovsky 2010). f 25,000 randomly selected human–mouse con-
served exons (Carmel et al. 2004). g 39,862 human exons from the
Alternative splicing Database (Stamm et al. 2006). The relative nucle-
otide frequencies at each position were plotted with a pictogram utility
available at http://genes.mit.edu/pictogram.html. The height of each
letter is proportional to the frequency of the corresponding base at the
given position394 Hum Genet (2010) 128:383–400
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competing 3ss as in U2AF35-depleted cells. Comparison
with the predicted strength of 3ss revealed that U2AF pro-
moted intrinsically weaker 3ss in 7 cases and stronger 3ss
in 4 cases, with both INS pairs in the latter category. Thus,
although we identiWed a number of new U2AF35-depen-
dent 3ss, this extended sample failed to show a clear bias
toward intron-proximal or intrinsically weaker sites.
A search for cis- and trans-acting regulators of INS exon 2 
inclusion
Because U2AF35 may function as a mediator of enhancer-
dependent splicing (Zuo and Maniatis 1996), we next car-
ried out a systematic deletion analysis of exon 2 to identify
putative enhancers promoting the 3ss of intron 1. Dele-
tions in the 5 half of this exon tended to induce IR,
whereas 3 deletions often promoted ES (Supplemental
Fig. 13a). Of 20 deletion constructs, two activated
cr3ss+81 (del3 and del9 in Supplemental Fig. 13b). Del9
improved the exonic portion of cr3ss+81 (CAG/C > CAG/
G), but only removal of exon positions 22–34 in del3
revealed a genuine long-range eVect. This deletion resulted
in a loss of a putative enhancer UGUGGA that has its 3
portion in a predicted single-stranded conformation (Sup-
plemental Fig. 13c). Point mutations of loop-closing base-
pairs and the Wrst loop G increased ES and IR, however,
they did not activate cr3ss+81. The highest ES was
observed for a G > C transversion predicted to form the Wrst
position of a GNUR-type tetraloop, but the double mutation
swapping the loop-closing nucleotides did not rescue the
splicing phenotype (Supplemental Fig. 13c, d). Apart from
del3, cr3ss+81 was also activated by distant single-nucleo-
tide substitutions +5C > T, +10C > T and +11T > C, all
located within »12 nt from the 3ss where U2AF35 may
bind (Wu et al., 1999). These changes repressed canonical
transcripts and proinsulin secretion (Supplemental
Fig. 13E-F) and altered putative binding sites for PTB, but
their splicing pattern in PTB-/neuronal PTB-depleted cells
was similar to that in untreated cells (data not shown).
Splicing enhancers, including the newly identiWed ele-
ment in INS exon 2, may interact with trans-acting factors
that promote exon 2 inclusion, such as SR proteins (Burge
et al.  1999). Individual depletion of human SR proteins
revealed that exogenous INS exon 2 was skipped in HeLa
cells treated with siRNAs targeting 9G8 (Fig. 7a,  left
panel). In addition, depletion of SRp20 was associated with
an increased representation of transcripts spliced to
cr3ss+126. Moreover, codepletion of the human homologs
of  D. melanogaster transformer-2 Tra2 and Tra2 was
associated with increased ES and IR. We observed similar
eVects with the reporter carrying the IVS1-6T allele (right
panel) and their speciWcity was also conWrmed by indepen-
dent siRNAs and rescue experiments with plasmids
expressing wild-type SR proteins (Fig. 7b). Finally, coex-
pression of a panel of SR proteins with INS reporters in
293T cells was associated with increased exon 2 inclusion.
In contrast, coexpression of INS with a subset of hnRNPs
appeared to promote exon skipping and/or cr3ss+126
(hnRNP C1 and F; Supplementary Fig. 14).
Discussion
Variable intron retention in the 5 untranslated region 
and coupled splicing and translation control
Our study is the Wrst to experimentally determine the eVects
of each disease gene variant/haplotype on splicing, mRNA
levels and protein expression. This was facilitated by the
small size of INS, the established allelic structure in several
human populations (Stead et al. 2003) and by the
haplotype-speciWc and highly transfectable reporter system
Fig. 7 SR proteins in INS splicing a INS splicing pattern in cells
depleted of SR proteins. HeLa cells were transfected with a battery of
optimized siRNAs individually targeting human SR or SR-related pro-
teins (shown at the top). Haplotype-speciWc construct and mutation are
shown at the bottom, RNA products to the right. b SpeciWcity of SR-
mediated  INS splicing for three SR proteins. EV empty vector
(pCR3.1), RP rescue plasmid expressing wild-type SR proteins shown
at the bottomHum Genet (2010) 128:383–400 395
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capable of secreting exogenous proinsulin (Fig. 1). The
overall proportion of variants that inXuenced splicing was
»20% (3/15), which is lower than estimates obtained for
RNA-based mutation screens of large disease genes with
many introns (Teraoka et al. 1999), but higher than that ini-
tially predicted for monogenic disease (Krawczak et al.
1992).
The higher proinsulin output from T1D-protective hap-
lotypes involved at least two levels of tightly coupled gene
expression pathways. A major determinant was the increase
of mRNA upon splicing (Fig. 1), in agreement with earlier
observations of diminished mRNA levels upon intron
removal from genomic constructs derived from several spe-
cies (Brinster et al. 1988; Rose 2004), including the rat pro-
insulin (Lu and Cullen 2003). This has been attributed to
the enhancement of RNA polymerase II initiation or pro-
cessivity (Furger et al. 2002), improved 3 end processing
(Lu and Cullen 2003) or modulation of nucleosome posi-
tions (Liu et al. 1995). The overall increase of gene expres-
sion by intron splicing was usually moderate, with the rat
proinsulin close to the average (Lu and Cullen 2003;
McKenzie and Brennan 1996).
Our work also shows that splice variants in the 5
untranslated region can alter gene expression through gain
of uORFs in a weakly spliced intron and extends the con-
cept of translational pathophysiology (Cazzola and Skoda
2000) to complex traits (Supplemental Fig. 8). Coupled
splicing and translation control is likely to reXect the rela-
tive depletion of ATGs in the 5 untranslated region from
yeasts to mammals and their higher level of conservation
than any other trinucleotides (Churbanov et al. 2005).
Upstream ORFs starting from conserved ATGs are, on
average, shorter than those starting from non-conserved
ATGs (uORF2 in Fig. 3). Thus, purifying selection against
deleterious ATGs has been accompanied by translation
attenuation through conserved upstream ATGs (Churbanov
et al. 2005). The lack of uORFs in orangutans (Fig. 3a) and
their distinct predicted branchpoint (Supplemental Fig. 6)
suggests that the translational/splicing control may be less
eVective, speculatively linking these features to the propen-
sity to diabetes proposed for this species (Gresl et al. 2000).
Splicing of INS intron 1 appears to be regulated during
early development in chicken and mouse (Mansilla et al.
2005). Embryonic proinsulin levels decreased from gastru-
lation to neurulation, but mRNAs increased, which was
attributed to the increasing amount of intron 1-containing
transcripts (Mansilla et al. 2005). Additional level of devel-
opmental regulation was shown in chicken embryos, in
which the transcriptional start site is extended 32 nt
upstream, introducing an extra upstream ATG (Hernandez-
Sanchez et al. 2003). Extending the 5 untranslated region
in our A–C reporters to accommodate the upstream ATG
creates an out-of-frame uORF with the authentic start
codon in correctly spliced RNAs but in-frame in intron 1-
containing transcripts. As the out-of-frame uORF dramati-
cally reduced proinsulin translation (Kralovicova et al.
2006a), future studies should establish if alternative tran-
scriptional initiation sites that are present in developing
vertebrates (Hernandez-Sanchez et al. 2003) also exist in
humans.
Balancing act of U2AF subunits in 3ss selection
Our study has identiWed the Wrst U2AF35-sensitive cryptic
3ss (Fig. 5) and extended the number of U2AF35-depen-
dent authentic 3ss (Supplemental Table 4), but did not Wnd
a clear bias toward intron-proximal or intrinsically weaker
sites. The latter Wnding is in agreement with a lack of corre-
lation between the requirement for either subunit and the
PPT length/sequence in S. pombe (Webb et al. 2005). In
addition, S. pombe introns that were most highly dependent
on the large subunit also exhibited a marked dependence on
the small subunit (Webb et al. 2005). Similarly, the direc-
tion of 3ss choice upon depletion of human subunits was
identical in each case (Supplemental Table 4). These results
are consistent with a competition rather than directional
scanning mechanism of 3ss selection, as supported by ear-
lier studies (Crotti and Horowitz 2009; Luukkonen and Ser-
aphin 1997; Patterson and Guthrie 1991).
Contrary to preferential inhibition of a subset of weak
3ss in U2AF35-depleted cells (Pacheco et al. 2006a),
intrinsically weaker 3ss were preferred at low U2AF35
concentration in both INS introns (Fig. 5; Supplemental
Table 2), supporting the importance of other factors in 3ss
selection. Activation of cr3ss+81 upon depletion of
U2AF35, but not U2AF65, is likely to reXect the speciWc
involvement of U2AF35 in the second step of splicing of
‘AG-dependent’ 3ss (Guth et al. 1999; Reed 1989), and is
consistent with an additional function of this molecule
besides stabilizing U2AF65 binding to the PPT (Guth et al.
2001). Our results suggest that the balance of U2AF sub-
units and their availability in nuclear speckles, probably in
complexes with splicing factor 1 (Rino et al. 2008), is
important for the accurate 3ss choice. However, U2AF35
depletion alters expression levels of additional mRNAs that
may themselves inXuence INS splicing or harbor U2AF35-
dependent 3ss; on the other hand, very few known splicing
factors were aVected (Pacheco et al. 2006b). Alternatively,
activation of weak cr3ss+81 in U2AF35-depleted cells
could be promoted by an upstream G-repeat that is likely to
act as an intronic splicing enhancer (Fig. 2a). In addition,
exon 2 segment upstream of cr3ss+81 lacks adenosines in
an optimal branchpoint consensus (Supplementary Fig. 13),
therefore this cryptic 3ss may use the same branchpoint/
PPT unit as its authentic counterpart. Moreover, cr3ss+81
has a consensus CAG/CC that deviates from the optimal396 Hum Genet (2010) 128:383–400
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U2AF35 binding site CAG/GT (Wu et al. 1999) and may
thus bind a U2AF35-related protein with a higher aYnity.
HeLa cells transfected with siRNAs targeting ZRSR2
(Tronchere et al. 1997) and U2AF26 (Shepard et al. 2002)
did not activate cr3ss+81, however, antibodies against
these proteins were not available to us and we could not
exclude ineYcient knockdown. Similarly, treatment of
HeLa cells with two siRNAs targeting SRrp53 (RSRC1),
which interacts with U2AF35 and CAPER and activates a
weak adenovirus 3ss with cytosines at exon positions +1+2
(Cazalla et al. 2005), did not induce cr3ss+81. Finally,
hSlu7 depletion also failed to activate this 3ss (J.K., I.V.,
unpublished data), which may be attributed to a larger dis-
tance from the predicted branch point of exon 2 beyond
which aberrant 3ss were not observed in hSlu7-depleted
extracts (Chua and Reed 1999).
Apart from U2AF35, U2AF65 depletion repressed a
stronger 3ss of intron 2 and promoted authentic but weaker
competitor (Fig. 4g). A BLAST search of expressed
sequence tags with a sequence string bridging the stronger
cr3ss+126 identiWed at least 13 transcripts in cDNA libraries
from insulinoma (n = 11) and isolated pancreatic islets
(n = 2) (J.K. and I.V., unpublished data). This suggests that
cr3ss+126 is selected with an appreciable frequency in
vivo, which was recapitulated in our reporters (Fig. 1d). As
U2AF65 binds to nascent transcripts immediately after
transcription and assists RNA polymerase II in returning to
transcriptional competence when it pauses downstream of a
PPT, a lack of U2AF65 would be predicted to increase
polymerase II pausing (Ujvári and Luse 2004). Promotion
of the authentic, intron-proximal 3ss may thus be
explained by longer dwell times at a pause site and a slower
elongation rate between the two competing 3ss of intron 2.
A putative model for RNA binding of U2AF35 ZF
ZFs are one of the most abundant protein domains in
eukaryotes, with over 50 C3H-type ZF proteins encoded in
the human genome, many involved in RNA metabolism,
immune responses and macrophage activation (Liang et al.
2008). Each cysteine and histidine of U2AF35 ZFs is
invariant from Xy to man, but the number of identical
amino acids in ZF orthologs is higher in ZF1 than in ZF2,
suggesting that ZF1 interacts with a more phylogenetically
conserved signal. Although both ZFs are likely to contrib-
ute to RNA binding, comparable mutations of the last three
ZF residues of the S. pombe ortholog were lethal for ZF1
but not for ZF2 (Webb et al. 2005). Because ZF proteins
often bind overlapping 4-nucleotide motifs (Hudson et al.
2004) (and references therein), it is tempting to speculate
that U2AF35 ZF1/ZF2 could bind the extended CAG/
RUUY consensus of the 3ss. In addition, since repeated
C3H motifs have been associated with RNase activity and
hairpin cleavage (Bai and Tolias 1996), it is conceivable
that U2AF35 ZFs may be directly involved in shaping the
3ss structure. Apart from U2AF35, INS intron 1 splicing
can also be regulated by other RNA-binding ZF proteins.
For example, tandem ZF3 and ZF4 of the alternative
splicing regulator MBNL1 were shown to preferentially
recognize sequences upstream of 3ss (Teplova and Patel
2008). Finally, because ZF proteins have a pivotal role in
the development of eukaryotes and are promising targets
for drug design, future studies should explore the potential
of ZF-based approaches to increase eYciency of intron 1
splicing, ultimately reducing IDDM2-mediated risk of
T1D.
U2AF35 as a possible mediator of environmental risk 
of T1D
The ZF domain structure is stabilized by zinc, but aYnities
of ZF domains/proteins vary over many orders of magni-
tude (Hanas et al. 2005). Zinc concentration in the cell is
low and zinc metalloproteins do not acquire this metal from
a pool of free ions (Finney and O’Halloran 2003); instead,
zinc uptake is maintained by metal traYcking proteins
(Jacob et al. 1998). As a result, zinc deWciency may impair
function of ZF proteins and diminish accurate recognition
of U2AF35-dependent 3ss. Interestingly, a long-term
exposure to high groundwater concentration of zinc was
associated with a decrease in T1D risk, particularly in rural
areas in which drinking water was taken from local wells
(Haglund et al. 1996), and this association was supported
independently (Zhao et al. 2001). Pretreatment with zinc
partially prevented diabetes induced by streptozocin (Yang
and Cherian 1994). In contrast, xenobiotic metals capable
of releasing zinc from ZF coordination spheres, such as
cadmium or mercury, would be predicted to increase the
T1D incidence. However, it should be emphasized that zinc
is important for a large number of biological reactions,
including packaging in secretory granules of  cells.
In addition to metals, 3ss requirement for U2AF35 may
be altered in virus-infected cells, as was demonstrated for
adenovirus (Lutzelberger et al. 2005). The small subunit
was also proposed to bind a Shigella e Vector IpaH9.8,
which may modulate cytokine expression and immune
responses (Okuda et al. 2005). Thus, a lack of zinc or
microbial infection in early pregnancy might interfere with
accurate expression of U2AF35-dependent transcripts.
U2AF35 as a mediator of the IDDM2-related risk of T1D
The increased dependency of the 3ss of intron 1 on
U2AF35 was due to its relaxation in Hominidae and out-of-
Africa Homo sapiens, which coevolved with the introduc-
tion of uORF2 (Fig. 3a) and splicing regulatory motifsHum Genet (2010) 128:383–400 397
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(Fig. 2, Supplemental Table 1). The requirement for
U2AF35 was limiting for splicing of the low-expressing
and T1D-predisposing allele IVS1-6A (Fig. 5b) and is
likely to be restrictive in vivo for transcripts containing
U2AF35-dependent 3ss, including those encoding other
autoantigens. In addition, location of speciWc T-cell epi-
topes in each proinsulin chain without a clear hot spot
argues for the importance of quantitative diVerences of INS
expression in the thymus because of the intron-mediated
enhancement (Supplementary Fig. 2b), and not by antigen
presentation of de novo peptides resulting from alternative
gene splicing.
Rather than being an all-or-none phenomenon, however,
U2AF35-dependency is likely to manifest as a continuous
spectrum of interactions that promote 3ss recognition,
including cross-exon contacts. U2AF35-related genes such
as ZRSR2, which is highly expressed in immune competent
cells (Su et al. 2004), and putative partners of U2AF35,
such as SR proteins (Wu and Maniatis 1993), may compen-
sate this restriction. This concept is in agreement with the
observed rescue of U2AF35-deWcient phenotype by
ZRSR2. Even if dependence on U2AF35 does not always
correlate with the presence of purine-rich enhancers (Guth
et al.  2001), future studies should attempt to identify
U2AF35 binding partners that contact INS e x o n  2 .  T h i s
exon is longer than the average and less likely to form a
continuous cross-exon protein network (Reed 1996; Zuo
and Maniatis 1996), thus providing more space for the acti-
vation of cr3ss+81. Our initial screening identiWed a subset
of SR proteins associated with increased inclusion of this
exon and also exon 2 residues required for activation of the
U2AF35-sensitive cr3ss+81 that were engaged in long-
range RNA interactions. Future studies should show that
these factors contact the INS pre-mRNA and identify their
binding sites. Notably, SRp20 RNA binding consensus
motifs (Cavaloc et al. 1999) can be found between
cr3ss+126 and its authentic counterpart (data not shown).
In addition, this protein was found to be abundantly
expressed in the thymus (Ayane et al. 1991).
Does INS VNTR confer genetic predisposition to T1D?
The role of VNTR in T1D was originally supported by
cross-haplotype studies, but reanalysis of more genotypes
in T1D families revealed that the previous exclusion of
intragenic variants was not warranted (Barratt et al. 2004).
VNTR-free reporter constructs carrying the T1D-protective
haplotype produced consistently higher levels of total pro-
insulin than plasmids with the T1D-predisposing haplotype
(Fig. 1c). The VNTR upstream of the class IC insert did not
inXuence INS splicing (Supplemental Fig. 1d). A previous
claim that haplotype-dependent mRNA levels cannot be
attributed to intragenic variants and must therefore reXect
the VNTR variability (Marchand and Polychronakos 2007;
Pugliese et al. 1997; VaWadis et al. 1997) is convincingly
refuted by this and many previous studies (Furger et al.
2002; Kwek et al. 2002; Lu and Cullen 2003) (and refer-
ences therein). A lack of intron 1-containing transcripts in
the foetal thymus where INS is expressed at very low levels
does not warrant the conclusion (Marchand and Polychro-
nakos 2007) that polymorphic splicing is irrelevant to T1D
predisposition, because even small decrease in splicing
kinetics in the developing thymus could reach a threshold
required for eYcient expression and presentation of self-
peptides in carriers of the susceptibility alleles. Although
putative long-range transcriptional eVects of VNTR on INS
expression cannot be excluded (Ladd et al. 2007), our study
oVers a plausible alternative explanation for the haplotype-
speciWc expression that had been attributed solely to the
VNTR (Lucassen et al. 1995; Pugliese et al. 1997). Impor-
tantly, the increased IR on the IC haplotypes was observed
in many cell types, including rat -cells, macrophages and
thymic epithelial cells (Kralovicova et al. 2006a; Marchand
and Polychronakos 2007) (Supplemental Fig. 2a) and also
in  INS pre-mRNAs transcribed from vectors carrying
weaker promoters (pGL3, J.K., unpublished data), consis-
tent with diVerential recognition of 3ss signals by key
components of the splicing machinery that are ubiquitously
expressed and highly conserved in evolution.
In conclusion, we have identiWed critical INS variants
responsible for the haplotype-speciWc expression and their
important interactions. U2AF35 contacts with 3ss of INS
intron 1 represent a new target for drug design to explore
the prophylactic potential of ZF proteins and reduce genetic
risk of T1D conferred by the strongest non-MHC locus.
Finally, these results challenge the VNTR hypothesis of
disease susceptibility and provide new insights into envi-
ronmental aspects of T1D aetiology.
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